+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Frontiers in Anti-Infective Drug Discovery: Volume 7

  • PDF Icon

    Book

  • May 2018
  • Bentham Science Publishers Ltd
  • ID: 4582132

This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.

Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.

The seventh volume of this series features 7 chapters that cover the following topics:


  • Gut micriobiota and gastrointestinal cancer
  • Dengue virus infections
  • Synergistic antibiotic drug interactions
  • Molecular modelling of antibacterial drugs
  • Nucleic acid aptamers as anti-infective agents
  • Fungal multidrug resistance
  • The role of hydrogen sulfide in infections

Table of Contents

Chapter 1 The Role Of The Microbiota In The Genesis Of Gastrointestinal Cancers 


  • Edda Russo And Amedeo Amedei
  • Introduction
  • The Human Microbiota 
  • The Gastrointestinal Microbiota 
  • Composition And Activities 
  • Gastro-Intestinal Colonization By The Microbiota And Selection
  • The Human Microbiome Project 
  • Gut Enterotypes
  • The Role Of Microbiota In Tumor Development
  • Proposed Models For Microbiota-Induced Carcinogenesis 
  • Antibacterial-Specific Immune Response And Cancer Promotion 
  • Microbiota And Gi Cancers 
  • Gut Bacteria Dysbiosis Associated With Gi Cancer 
  • Microbiota Involvement In Gastric And Esophageal Cancers, The Role Of Helicobacter Pylori 
  • Microbiota Involvement In Colorectal Cancer
  • Specific Gut Bacteria And Crc 
  • Bacteria Metabolites And Crc 
  • Gallbladder Cancer 
  • Liver Cancer 
  • Pancreatic Cancer 
  • Beneficial Activities Of Gut Microbiota
  • Antitumorigenic Impact Of Microbiota 
  • Manipulating The Microbiota For Cancer Therapy 
  • Conclusion
  • Consent For Publication 
  • Conflict Of Interest 
  • Acknowledgements 
  • References 

Chapter 2 Towards Host Cell-Targeting Therapies To Treat Dengu Virus Infections 


  • Cybele C García, Verónica M Quintana, Viviana Castilla And Elsa B Damonte
  • Introduction 
  • Interaction With Cell Receptors 
  • Endocytosis And Fusion For Uncoating 
  • Lipid Metabolism 
  • Protein Translation 
  • Unfolded Protein Response 
  • Ubiquitin Proteasome Pathway 
  • Nucleotide Metabolism 
  • Kinases 
  • Mitogen-Activated Protein Kinases 
  • Erk Pathway 
  • Jnk Pathway 
  • P38 Pathway 
  • Other Kinases 
  • Src, Ab1 And Fyn Kinases 
  • Ap2-Associated Protein Kinase 1 And Cyclin G-Associated Kinase 
  • Phosphatidylinositol 3 Kinase/Akt Pathway 
  • Protein Processing 
  • Endoplasmic Reticulum A-Glucosidases 
  • Furin 
  • Endoplasmic Reticulum Associated Signal Peptidase 
  • Innate Antiviral Response 
  • Interferon Activity 
  • Cell-Intrinsic Restriction Factors 
  • Concluding Remarks 
  • Consent For Publication 
  • Conflict Of Interest 
  • Acknowledgements 
  • References 

Chapter 3 Synergistic Interaction Between Plant Products And Antibiotics Against Potential Pathogenic Bacteria 


  • Banasri Hazra, Sutapa Biswas Majee, Subhalakshmi Ghosh And Dhruti Avlani
  • Introduction 
  • Bacterial Resistance Towards Clinical Antibiotics 
  • Background 
  • Mechanisms And Associated Factors 
  • Screening Strategies To Characterise Plant Products With
  • Potential Resistance Modifying Activity 
  • Assessment Of Synergistic Interaction Between Antibiotic And A
  • Phytocompound Against Resistant Bacteria 
  • Fractional Inhibitory Concentration Index (Fici) 
  • Modulation Factor (Mf) 
  • Isobologram 
  • Search For Plant-Derived Secondary Metabolites With
  • Prospective Resistance Modifying Activity 
  • Key Early Studies Pertaining To Discovery Of Rmas From Plants 
  • Recent Studies 
  • Phytochemicals And Relevant Bacterial Resistance Mechanisms
  • Efflux Pump Inhibition 
  • Alteration Of Bacterial Cell Membrane Permeability 
  • Protein Synthesis Inhibition 
  • Enzymatic Inhibition 
  • Biofilm Formation Inhibition 
  • Additional Strategies For Screening And Development Of Plant
  • Products As Adjuvants In Antimicrobial Therapy 
  • In Vivo Validation 
  • Standardisation Of Botanical Extracts 
  • Ichip Technology 
  • Concluding Remarks 
  • Consent For Publication 
  • Conflict Of Interest 
  • Acknowledgements 
  • Abbreviations 
  • References 

Chapter 4 Molecular Modelling Approaches To Antibacterial Drug Design And Discovery 


  • Agnieszka A Kaczor, Prasanthi Medarametla, Damian Bartuzi, Magdalena Kondej,
  • Dariusz Matosiuk And Antti Poso
  • Introduction 
  • Challenges In Design And Discovery Of Antibacterial Drugs 
  • Drug Targets For Antibiotics 
  • Molecular Modelling Techniques For Design And Discovery Of
  • Antibacterial Drugs 
  • Protein 3D Structure Prediction 
  • Comparative/Homology Modelling 
  • Fold Recognition/Threading 
  • Ab Initio Modelling 
  • Protein Structure Prediction In Anti-Bacterial Drug Design 
  • Molecular Docking 
  • Molecular Docking As An Approach To Study Ligand-Protein Interactions 
  • Application Of Molecular Docking In Anti-Bacterial Drug Discovery 
  • Molecular Dynamics 
  • Molecular Dynamics As An Approach To Study Dynamic Aspects Of Ligand-Protein
  • Interactions 
  • Application Of Molecular Dynamics For Antibacterial Drug Discovery 
  • Qsar 
  • Qsar As A Method Applied In Drug Design 
  • Application Of Qsar For Antibacterial Drug Discovery 
  • Pharmacophore Models 
  • Importance Of Pharmacophore Models In Drug Design 
  • Application Of Pharmacophore Models For Antibacterial Drug Discovery 
  • Virtual Screening 
  • Virtual Screening As A Method Of Searching Large Databases 
  • Application Of Virtual Screening For Antibacterial Drug Discovery 
  • Prediction Of Drug-Likeness And Admet Properties 
  • Summary And Perspective 
  • Consent For Publication 
  • Conflict Of Interest 
  • Acknowledgements 
  • References 

Chapter 5 Nucleic Acid Aptamers Against Virulence Factors Of Drug Resistant Pathogens 


  • Canan Ozyurt, Ozge Ugurlu, Burhan Bora And Serap Evran
  • Introduction 
  • Selection Of Aptamers 
  • Aptamers Against Toxins And Protein Virulence Factors 
  • Aptamers Against Staphylococcal Toxins 
  • Aptamers Against Clostridium Toxins 
  • Aptamers Against E Coli Toxins 
  • Aptamers Against Aspergillus And Penicillium Toxins 
  • Aptamers Against Mycobacterium Tuberculosis Toxins 
  • Aptamers Against Other Toxins 
  • Aptamers Against Quorum Sensing Molecules 
  • Modifications Of Aptamers For Improving Therapeutic Potential 
  • 2'-F-Modified Rna Aptamers 
  • 2'-Nh2 Modification Of Aptamers 
  • Other Ribose Modified Aptamers 
  • Phosphorothioate Modification 
  • Nucleobase Modification Of Aptamers 
  • Concluding Remarks 
  • Consent For Publication 
  • Conflict Of Interest 
  • Acknowledgement 
  • References 

Chapter 6 Overcoming Fungal Multidrug Resistance By Natural Compounds Targeting Efflux Pumps 


  • Shweta Singh, Sandeep Hans, Zeeshan Fatima
  • And Saif Hameed
  • Introduction 
  • Candida Efflux Pumps 
  • Abcs Transporter Family 
  • Mfs Transporter Family 
  • Natural Epi Targeting Abc Transporters 
  • Natural Epi Targeting Mfs Transporters 
  • Conclusion 
  • Consent For Publication 
  • Conflict Of Interest 
  • Acknowledgements 
  • References 

Chapter 7 The Infections And Hydrogen Sulfide 

Author

  • Atta-ur-Rehman
  • Iqbal Chaudhry